WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

S SENSORY ORGANS

A formulation approved both for use in the eye/ear is classified in S03. Formulations approved for eye, ear and nose are also classified in S03. Formulations only licensed for use in the eye or the ear are classified in S01 and S02, respectively.


S01 OPHTHALMOLOGICALS

Most of the drugs in this group are topical preparations. Systemic preparations with clear ophthalmological indications are also classified in this group.
Small amounts of antiseptics in eye preparations do not influence the classification, e.g. benzalconium.
See also S03 - Ophthalmological and otological preparations.

DDDs have been assigned for antiglaucoma preparations only.


S01K SURGICAL AIDS

This group comprises drugs used in ophthalmological surgery.
Miotics are classified in S01E - Antiglaucoma preparations and miotics.
Mydriatics and cycloplegics are classified in S01F.


S01KA Viscoelastic substances

Hyaluronic acid injection used during surgical procedures on the eye (e.g. 4-20 mg/ampoule) is classified in this group. Hyaluronic acid injection for intra-articular administration (e.g. 2.5 mg/ampoule) used in the treatment of arthritis is classified in M09A - Other drugs for disorders of the musculo-skeletal system.
Hypromellose is classified in this group. Hypromellose used as artificial tears is, however, classified in S01XA20.

S01KX Other surgical aids

Preparations containing e.g. enzymes (chymotrypsin) for use in eye surgery, are classified in this group.
Mitomycin used in glaucoma surgery is classified in L01DC03.

Last updated: 2024-01-26